E-LIB Suche - Ergebnisse für: Vickery, Brian P

1

Exploratory immunogenicity outcomes of peanut oral immunoth..:

Nilsson, Caroline ; Vereda, Andrea ; Borres, Magnus P....
Clinical and Translational Allergy. 14 (2024) 1 - p. , 2024

2

The Future of Food Allergy Management: Advancements in Ther..:

Ezhuthachan, Idil D. ; Beaudoin, Michele ; Nowak-Wegrzyn, Anna.
Current Allergy and Asthma Reports. 24 (2024) 4 - p. 161-171 , 2024

Link: https://doi.org/10.1007/..

3

The Intersection of Autism Spectrum Disorder, Food Allergy,..:

Proctor, Kaitlin B. ; Volkert, Valerie M. ; Klin, Ami..
The Journal of Pediatrics. 269 (2024) - p. 113965 , 2024

Link: https://doi.org/10.1016/..

4

Comment on Hill and colleagues:

Proctor, Kaitlin B. ; Sharp, William G. ; Vickery, Brian P.
Pediatric Allergy and Immunology. 35 (2024) 5 - p. , 2024

Link: https://doi.org/10.1111/..

5

Retail Food Equivalents for Post–Oral Immunotherapy Dosing ..:

Groetch, Marion ; Mudd, Kim ; Woch, Margaret...
The Journal of Allergy and Clinical Immunology: In Practice. 11 (2023) 2 - p. 572-580.e2 , 2023

Link: https://doi.org/10.1016/..

6

Randomized controlled trial of slow peanut oral immunothera..:

Uhl, Carina ; Sverremark‐Ekström, Eva ; Borres, Magnus...
Clinical & Experimental Allergy. 53 (2023) 5 - p. 594-597 , 2023

Link: https://doi.org/10.1111/..

7

Protocol design and synopsis: Omalizumab as Monotherapy and..:

Wood, Robert A. ; Chinthrajah, R. Sharon ; Rudman Spergel, Amanda K....
Journal of Allergy and Clinical Immunology: Global. 1 (2022) 4 - p. 225-232 , 2022

Link: https://doi.org/10.1016/..

8

Kinetics of basophil hyporesponsiveness during short-course..:

Kulis, Michael D. ; Smeekens, Johanna M. ; Burk, Caitlin...
Journal of Allergy and Clinical Immunology. 150 (2022) 5 - p. 1144-1153 , 2022

Link: https://doi.org/10.1016/..

9

Safety of peanut (Arachis hypogaea) allergen powder-dnfp in..:

Brown, Kari R. ; Baker, James ; Vereda, Andrea...
Journal of Allergy and Clinical Immunology. 149 (2022) 6 - p. 2043-2052.e9 , 2022

Link: https://doi.org/10.1016/..

10

Participant characteristics and safety outcomes of peanut o..:

Ciaccio, Christina ; Goldsobel, Alan B. ; Anagnostou, Aikaterini...
Annals of Allergy, Asthma & Immunology. 129 (2022) 6 - p. 758-768.e4 , 2022

Link: https://doi.org/10.1016/..

11

Current and future treatments for peanut allergy:

Lee, Tricia ; Edwards‐Salmon, Sofia ; Vickery, Brian P.
Clinical & Experimental Allergy. 53 (2022) 1 - p. 10-24 , 2022

Link: https://doi.org/10.1111/..

12

Oral desensitization therapy for peanut allergy induces dyn..:

Bajzik, Veronique ; DeBerg, Hannah A. ; Garabatos, Nahir...
Allergy. 77 (2022) 8 - p. 2534-2548 , 2022

Link: https://doi.org/10.1111/..

13

Manufacturing processes of peanut (Arachis hypogaea) allerg..:

Leonard, Stephanie A. ; Ogawa, Yasushi ; Jedrzejewski, Paul T....
Frontiers in Allergy. 3 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

14

Continuous and Daily Oral Immunotherapy for Peanut Allergy:..:

Vickery, Brian P. ; Vereda, Andrea ; Nilsson, Caroline...
The Journal of Allergy and Clinical Immunology: In Practice. 9 (2021) 5 - p. 1879-1889.e13 , 2021

Link: https://doi.org/10.1016/..

15

Open‐label follow‐on study evaluating the efficacy, safety,..:

Fernandez‐Rivas, Montserrat ; Vereda, Andrea ; Vickery, Brian P....
Allergy. 77 (2021) 3 - p. 991-1003 , 2021

Link: https://doi.org/10.1111/..